
    
      Multi center evaluation of the Millipede IRIS for treatment of clinically significant mitral
      regurgitation in subjects determined appropriate for mitral valve surgery.

      This trial is designed in accordance with the 2014 ACC/AHA guidelines for valvular heart
      disease, and the consensus statement of MVARC 2015.

      Subjects will undergo transcatheter implantation of the Millipede IRIS implant.
    
  